|
|
A PLATFORM TRIAL DESIGN TO ACCELERATE TRANSLATIONAL THERAPIES IN A CANINE DISEASE MODEL OF ALS |
| 5R21TR002277-02 |
COATES, JOAN RIPLEY |
NCATS |
2019 |
|
|
TISSUE-SPECIFIC MODULATION OF APOLIPOPROTEIN E IN NEURODEGENERATION |
| 1F30AG066373-01 |
FERGUSON, CHANTAL |
NIA |
2019 |
|
|
IMPEDING TRANSCRIPTION OF EXPANDED MICROSATELLITE REPEATS USING DEACTIVATED CAS9 |
| 1R01AG058636-01A1 |
WANG, ERIC T |
NIA |
2019 |
|
|
NOVEL PROTEIN AGGREGATION INHIBITORS AND UPPER MOTOR NEURON STABILIZERS FOR ALS AND OTHER NEURODEGENERATIVE DISEASES |
| 1R01AG061708-01A1 |
OZDINLER, PEMBE HANDE |
NIA |
2019 |
|
|
MITOCHONDRIAL TDP-43 IN ALZHEIMER'S DISEASE |
| 1RF1AG056320-01A1 |
WANG, XINGLONG |
NIA |
2019 |
|
|
NOVEL GENETIC MODIFIERS OF C9ORF72 AND TAU TOXICITY |
| 1RF1AG062077-01 |
FRYER, JOHN DAVID |
NIA |
2019 |
|
|
DETERMINE HOW LOSS-OF-FUNCTION OF THE TBK1 KINASE CAUSES AGE-DEPENDENT DEGENERATION IN FRONTOTEMPORAL DEMENTIA |
| 5F32AG059358-02 |
YU, HAIYANG |
NIA |
2019 |
|
|
NON-INVASIVE TRACKING OF GENOME-CORRECTED IPS CELLS IN ALS |
| 1UH2EB028904-01 |
BULTE, JEFF W |
NIBIB |
2019 |
|
|
IMPACT OF SEROTONIN DEFICIENCY ON SPEECH AND SWALLOW FUNCTION IN A MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| 5R21DC016071-02 |
LEVER, TERESA E |
NIDCD |
2019 |
|
|
ABNORMAL MATRIN 3 TURNOVER AND NUCLEIC ACID-BINDING IN ALS AND RELATED DISORDERS |
| 1F31NS110119-01A1 |
MALIK, AHMED MUGHEES |
NINDS |
2019 |
